Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shekhar

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Brain and Cognition|May 10, 2005
Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophreniaS M Brown, P D Kieffaber, C A Carroll, et al.
Molecular and Cellular Biochemistry|August 24, 2010
Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activityRiyaz Mohamed, K K Dharmappa, Shaista Tarannum, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
Translational Psychiatry|August 16, 2018
PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSDL- P Li, E T Dustrude, M M Haulcomb, et al.
Circulation. Arrhythmia and Electrophysiology|November 27, 2024
Self-Administered Etripamil Nasal Spray Relieved Symptoms, Decreased Heart Rate, and Reduced Medical Interventions During Atrioventricular Nodal-Dependent Paroxysmal Supraventricular TachycardiaBruce S Stambler, Benoit Coutu, James E Ip, et al.
Psychopharmacology|October 18, 2001
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disordersA Shekhar, U D McCann, M J Meaney, et al.
Molecular Psychiatry|August 25, 2025
Next-generation precision medicine for painR Bhagar, H Le-Niculescu, S C Corey, et al.
Molecular Psychiatry|April 8, 2021
Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugsH Le-Niculescu, K Roseberry, S S Gill, et al.
Molecular Psychiatry|February 7, 2024
Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomicsM D Hill, S S Gill, H Le-Niculescu, et al.
Molecular Psychiatry|March 6, 2023
Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugsK Roseberry, H Le-Niculescu, D F Levey, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Brain and Cognition|May 10, 2005
Eyeblink conditioning deficits indicate timing and cerebellar abnormalities in schizophreniaS M Brown, P D Kieffaber, C A Carroll, et al.
Molecular and Cellular Biochemistry|August 24, 2010
Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activityRiyaz Mohamed, K K Dharmappa, Shaista Tarannum, et al.
CJC Open|June 23, 2022
Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI StudyMilan Gupta, G B John Mancini, Rajvi J Wani, et al.
Translational Psychiatry|August 16, 2018
PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSDL- P Li, E T Dustrude, M M Haulcomb, et al.
Circulation. Arrhythmia and Electrophysiology|November 27, 2024
Self-Administered Etripamil Nasal Spray Relieved Symptoms, Decreased Heart Rate, and Reduced Medical Interventions During Atrioventricular Nodal-Dependent Paroxysmal Supraventricular TachycardiaBruce S Stambler, Benoit Coutu, James E Ip, et al.
Psychopharmacology|October 18, 2001
Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disordersA Shekhar, U D McCann, M J Meaney, et al.
Molecular Psychiatry|August 25, 2025
Next-generation precision medicine for painR Bhagar, H Le-Niculescu, S C Corey, et al.
Molecular Psychiatry|April 8, 2021
Precision medicine for mood disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugsH Le-Niculescu, K Roseberry, S S Gill, et al.
Molecular Psychiatry|February 7, 2024
Precision medicine for psychotic disorders: objective assessment, risk prediction, and pharmacogenomicsM D Hill, S S Gill, H Le-Niculescu, et al.
Molecular Psychiatry|March 6, 2023
Towards precision medicine for anxiety disorders: objective assessment, risk prediction, pharmacogenomics, and repurposed drugsK Roseberry, H Le-Niculescu, D F Levey, et al.
Pageof 9